It was a very strong week for the IPO market as six IPOs came to market…three closing the week more than 35% above their respective offering prices. The best deal this week was the Roku Inc. (ROKU) offering. The deal, according to our sources, had some initial push-back, but ended up pricing at the high[…]
Weekly Secondary Review: 9/25/17 – 9/29/17
You can Subscribe to IPO Boutique’s Secondary Only Service by clicking here: This past week 14 secondary offerings came to market and IPO Boutique placed BUY ratings on 7 of them. In all, $3.8bn was raised by companies in the secondary market this week. The average gain of IPO Boutique BUY rated offerings this week[…]
September IPO Recap – Judging IPO Boutique’s Performance
SUBSCRIBE TO IPOBoutique’s Free Weekly Newsletter In August, the IPO Market saw 14 companies go public for a total cash raise of $2.51bn. This included just one offering that raised more that $500m — PQ Group Holdings (PQG) — but also a heavy contingency of foreign offerings. Five out of the 14 IPOs this past month[…]
Rhythm Pharmaceuticals (RYTM) #IPO Preview
Company: Rhythm Pharmaceuticals Symbol: RYTM Description: They are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders. Shares: 6.67 million Price Range: $14.00-$16.00 Trade Date: 10/5 Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen & Co. Co-Manager(s): Needham & Co.[…]
Switch, Inc. (SWCH) #IPO Preview
Company: Switch, Inc. Symbol: SWCH Description: They believe the future of the connected world depends on the sustainable and cost-effective growth of the internet and the services it enables. Shares: 31.25 million Price Range: $14.00-$16.00 Trade Date: 10/6 Underwriter(s): Goldman Sachs & Co., J.P. Morgan, BMO Capital Markets, Wells Fargo Securities Co-Manager(s): Citigroup, Credit Suisse,[…]
IPO Pipeline: New Filings & Updated Terms (Week ending 9.29.17)
IPO Boutique keeps apprised of the active pipeline. Currently there are 69 active IPOs in the pipeline as of September 29, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. Company: Sea Limited Symbol:[…]
Secondaries Announced 09.28.2017
Company: Nexstar Media Group, Inc. Symbol: NXST Price: Last trade $62.20 Trade Date: 9/29 Shares: 641,240 Re-Offer Range: Subscription Needed Underwriter(s) : Raymond James Description: Nexstar Media Group, Inc. operates as a television broadcasting and digital media company in the United States. Rating: Rating=Subscription Needed Company: Hilton Worldwide Holdings Inc.-BLOCK Symbol: HLT Price: Last trade[…]
Secondaries Announced 9.26.17
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
Secondaries Announced 9.25.17
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
Weekly Secondary Review: 9/18/17 – 9/22/17
You can Subscribe to IPO Boutique’s Secondary Only Service by clicking here: This past week 12 secondary offerings came to market and IPO Boutique placed BUY ratings on 8 of them. In all, $2.3bn was raised by companies in the secondary market this week — a far cry from the $7.2bn raised last week. The[…]
IPO Weekly Recap: Zai Lab, Best Inc shine on Wednesday to remember
It was a very strong week for the IPO market as four of the seven IPOs opened with greater than a 10% premium at first trade. The best deal this week was the Zai Lab Limited (Nasdaq: ZLAB) offering. The offering upsized from 5.88mm shares to 8.0mm shares and priced at the high-end of[…]
Roku Inc (ROKU) IPO Preview
Company: Roku, Inc. Symbol: ROKU Description: They pioneered streaming to the TV. Roku connects users to the streaming content they love, enables content publishers to build and monetize large audiences, and provides advertisers with unique capabilities to engage consumers. Shares: 15.7 million Price Range: $12.00-$14.00 Trade Date: 9/28 Underwriter(s): Morgan Stanley, Citigroup, Allen & Co.,[…]
IPO Pipeline: Seven New Filings added to pipeline (Week ending 9-22-17)
IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of September 22, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article. Additionally, the ordinary retail[…]
PQ Group Holdings (PQG) IPO Preview
Company: PQ Group Holdings Inc. Symbol: PQG Description: They are a leading global provider of catalysts, specialty materials and chemicals, and services that enable environmental improvements, enhance consumer products, and increase personal safety. Shares: 29 million Price Range: $21.00-$23.00 Trade Date: 9/29 Underwriter(s): Morgan Stanley, Goldman Sachs & Co., Citigroup, Credit Suisse Co-Manager(s): J.P. Morgan,[…]
Nucana plc (NCNA) IPO Preview
Company: Nucana PLC Symbol: NCNA Description: They are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. Shares: 6.67 million ADSs Price Range: $14.00-$16.00 Trade Date: 9/28 Underwriter(s):[…]
Secondaries Announced 9.21.17
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]
Nightstar Therapeutics Limited (NITE) IPO Preview
Company: Nightstar Therapeutics Limited Symbol: NITE Description: They are a leading clinical-stage gene therapy company focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. Shares: 5.36 million ADSs Range: $13.00-$15.00 Trade Date: 9/28 Underwriter(s): Jefferies, Leerink Partners, BMO Capital Markets Co-Manager(s): Wedbush[…]
Deciphera Pharmaceuticals (DCPH) IPO Preview
Company: Deciphera Pharmaceuticals Symbol: DCPH Description: They are a clinical-stage biopharmaceutical company developing new drugs to improve the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response of many cancer therapies. Shares: 6.25 million Price Range: $15.00-$17.00 Trade Date: 9/28 Underwriter(s): J.P. Morgan, Piper Jaffray[…]
RYB Education, Inc #IPO Preview
Company: RYB Education, Inc. Symbol: RYB Description: They are the largest early childhood education service provider in China, as measured by annual total revenues in 2016, according to the Frost & Sullivan Report. Shares: 7.8 million ADSs Range: $16.00-$18.00 Trade Date: 9/27 Underwriter(s): Credit Suisse, Morgan Stanley Co-Manager(s): CICC, BNP PARIBAS Link to S-1/A Prospectus[…]
Secondaries Announced 9.20.17
IPO BOUTIQUE CLIENTS and IPO BOUTIQUE SECONDARY ALERTS CLIENTS received ALL this information to their inbox on a REAL TIME basis. If having real-time alerts for secondary offerings would be an advantage to you, inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]